A neurotensin agonist and antagonist decrease and increase activity, respectively, but do not preclude discrete cue conditioning.
There is evidence to suggest that neurotensin (NT) may enhance cognitive function. For example, in aversive trace conditioning, the NT agonist PD149163 selectively increased trace conditioning (Grimond-Billa, et al., 2008). The present study, therefore, examined the role of NT in associative learning, tested using an appetitive trace conditioning procedure (0-s or 10-s inter-stimulus-interval [ISI]) with a mixed frequency noise as a conditioned stimulus (CS) and food delivery as the unconditioned stimulus (UCS). The effects of an NT agonist (PD149163, 0.125 and 0.25 mg/kg, Experiment 1) and an NT antagonist (SR142948A, 0.01 and 0.1 mg/kg, Experiment 2) were compared. To take nonspecific effects of these compounds into account, conditioning to the CS was measured as a percentage of total responding, during UCS deliveries and in the inter-trial-interval (ITI). In both experiments, associative learning to the contiguously (0-s) presented CS was demonstrated, although there was a relative reduction in this learning under 0.125 mg/kg PD149163. Counter to prediction, the only effect on trace conditioning was some overall reduction in responding to the CS in the 10-s group conditioned under 0.25 mg/kg PD149163. The NT antagonist was without any effect on appetitive conditioning. However, these NT compounds were not ineffective: decreases and increases in responding in the ITI, ISI and during UCS deliveries seen under PD149163 and SR142948A were dissociable from effects on discrete cue conditioning.
Norman
C
C
Institute of Neuroscience, School of Biomedical Sciences, University of Nottingham, Nottingham, UK.
Grimond-Billa
S K
SK
Bennett
G W
GW
Cassaday
H J
HJ
D000218:Adamantane / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D001070:Appetitive Behavior / Q000187:drug effects; D001245:Association Learning / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D009496:Neurotensin / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018028:Receptors, Neurotensin / Q000819:agonists* / Q000037:antagonists & inhibitors*
D007093:Imidazoles; C117269:PD 149163; D018028:Receptors, Neurotensin; C104418:SR 142948A; D009496:Neurotensin; D000218:Adamantane